Molecular facets of sphingolipids: Mediators of diseases

Biotechnology Journal

Volumn 4, Issue 7, 2009, Pages 1028-1041

  Ozbayraktar, Fatma Betul Kavun ^a   Ulgen, Kutlu O ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Cancer; Ceramide; Location and transport; Sphingolipid metabolism; Sphingolipidoses

Indexed keywords

APOPTOSIS; CANCER; CERAMIDE; SPHINGOLIPID METABOLISM; SPHINGOLIPIDOSES;

AMIDES; BIOCHEMISTRY; CELL DEATH; CELL PROLIFERATION; LAWS AND LEGISLATION; LIPIDS; METABOLISM; PATHOLOGY;

CELL MEMBRANES;

SPHINGOLIPID;

APOPTOSIS; BONE MARROW TRANSPLANTATION; CANCER THERAPY; CARDIOVASCULAR DISEASE; CELL AGING; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL FATE; CELL MEMBRANE; CELL PROLIFERATION; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM; ENZYME MECHANISM; ENZYME REPLACEMENT; FABRY DISEASE; FARBER DISEASE; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; GOLGI COMPLEX; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPID TRANSPORT; LIPIDOSIS; LYSOSOME; MALIGNANT NEOPLASTIC DISEASE; METACHROMATIC LEUKODYSTROPHY; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE;

ANIMALS; CARDIOVASCULAR DISEASES; CERAMIDES; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; SPHINGOLIPIDOSES; SPHINGOLIPIDS;

SACCHAROMYCES CEREVISIAE;

EID: 70350228425     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800322     Document Type: Review

References (55)

1. Ogretmen, B., Sphingolipids in cancer: Regulation of pathogenesis and therapy. FEBS Lett. 2006, 580, 5467-5476.
2. Dickson, R. C., New insights into sphingolipid metabolism and function in budding yeast. J. Lipid Res. 2008, 49, 909-921.
3. Modrak, D. E., Gold, D. V., Goldenberg, D. M., Sphingolipid targets in cancer therapy. Mol. Cancer Ther. 2006, 5, 200-208.
4. Hannun, Y. A., Obeid, L. M., The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind. J. Biol. Chem. 2002, 277, 25847-25850.
5. Futerman, A. H., Riezman, H., The ins and outs of sphingolipid synthesis. Trends Cell Biol. 2005, 15, 312-318.
6. Dickson, R. C., Lester, R. L., Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta 1999, 1438, 305-321.
7. Dickson, R. C., Lester, R. L., Sphingolipid functions in Saccharomyces cerevisiae. Biochim. Biophys. Acta 2002, 1583, 13-25.
8. Le Stunff, H., Peterson, C., Liu, H., Milstien, S. et al., Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim. Biophys. Acta 2002, 1582, 8-17.
9. Alvarez-Vasquez, F., Sims, K.J., Hannun, Y.A., Voit, E.O., Integration of kinetic information on yeast sphingolipid metabolism in dynamical pathway models. J. Theor. Biol. 2004, 226, 265-291.
10. Sims, K. J., Spassieva, S. D., Voit, E. O., Obeid, L. M., Yeast sphingolipid metabolism: Clues and connections. Biochem. Cell Biol. 2004, 82, 45-61.
11. Cowart, L. A., Obeid, L. M., Yeast sphingolipids: Recent developments in understanding biosynthesis, regulation, and function. Biochim. Biophys. Acta 2007, 1771, 421-431.
12. Hait, N. C., Oskeritzian, C. A., Paugh, S. W., Milstien, S. et al., Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 2006, 1758, 2016-2026.
13. Perry, R. J., Ridgway, N. D., Molecular mechanisms and regulation of ceramide transport. Biochim. Biophys. Acta 2005, 1734, 220-234.
14. Vallee, B., Riezman, H., Lip1p: A novel subunit of acyl-CoA ceramide synthase. EMBO J. 2005, 24, 730-741.
15. Reggiori, F., Conzelmann, A., Biosynthesis of inositol phosphoceramides and remodeling of glycosylphosphatidylinositol anchors in Saccharomyces cerevisiae are mediated by different enzymes. J. Biol. Chem. 1998, 273, 30550-30559.
16. Funato, K., Vallee, B., Riezman, H., Biosynthesis and trafficking of sphingolipids in the yeast Saccharomyces cerevisiae. Biochemistry 2002, 41, 15105-15114.
17. Ogretmen, B., Hannun, Y. A., Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 2004, 4, 604-616.
18. Hanada, K., Kumagai, K., Tomishige, N., Kawano, M., CERT and intracellular trafficking of ceramide. Biochim. Biophys. Acta 2007, 1771, 644-653.
19. Kolter, T., Sandhoff, K., Sphingolipid metabolism diseases. Biochim. Biophys. Acta 2006, 1758, 2057-2079.
20. Van Meer, G., Holthuis, J. C. M., Sphingolipid transport in eukaryotic cells. Biochim. Biophys. Acta 2000, 1486, 145-170.
21. Tardy, C., Andrieu-Abadie, N., Salvayre, R., Levade, T., Lysosomal storage diseases: Is impaired apoptosis a pathogenic mechanism? Neurochem. Res. 2004, 29, 871-880.
22. Marks, D. L., Pagano, R. E., Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Biol. 2002, 12, 605-613.
23. Pagano, R. E., Puri, V., Dominguez, M., Marks, D. L., Membrane traffic in sphingolipid storage diseases. Traffic 2000, 1, 807-815.
24. Pagano, R. E., Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos.Trans. R. Soc. Lond., B, Biol. Sci. 2003, 358, 885-891.
25. Sandhoff, K., The biochemistry of sphingolipid storage diseases. Angew. Chem., Int. Ed. Engl. 1977, 16, 273-285.
26. Brady, R., Enzymatic abnormalities in diseases of sphingolipid metabolism. Clin. Chem. 1967, 14, 565-577.
27. Ozkara, H. A., Topcu, M., Sphingolipidoses in Turkey. Brain Dev. 2004, 26, 363-366.
28. Eng, C. M., Fletcher, J., Wilcox, W. R., Waldek, S. et al., Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J. Inherit. Metab. Dis. 2007, 30, 184-192.
29. Lukacs, Z., Hartung, R., Beck, M., Keil, A. et al., Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patients. J. Inherit. Metab. Dis. 2007, 30, 614.
30. Hein, L. K., Meikle, P. J., Hopwood, J. J., Fuller, M., Secondary sphingolipid accumulation in a macrophage model of Gaucher disease. Mol. Genet. Metab. 2007, 92, 336-345.
31. Ory, D. S., Niemann-Pick type C: A disorder of cellular cholesterol trafficking. Biochim. Biophys. Acta 2000, 1529, 331-339.
32. Soldati, T., Rancan, C., Geissler, H., Pfeffer, S. R., Rab7 and Rab9 are recruited onto late endosomes by biochemically distinguishable processes. J. Biol. Chem. 1995, 270, 25541-25548.
33. Ariga, T., Jarvis, W. D., Yu, R. K., Role of sphingolipid-mediated cell death in neurodegenerative diseases. J. Lipid Res. 1998, 39, 1-16.
34. Levade, T., Malagarie-Cazenave, S., Gouazé, V., Ségui, B. et al., Ceramide in apoptosis: A revisited role. Neurochem. Res. 2002, 27, 601-607.
35. Ségui, B., Andrieu-Abadie, N., Jaffrézou, J.-P., Benoist, H. et al., Sphingolipids as modulators of cancer cell death: Potential therapeutic targets. Biochim. Biophys. Acta 2006, 1758, 2104-2120.
36. Hirabayashi, Y., Igarashi, Y., Merrill, A. H. Jr. (Eds.), Sphinolipid Biology, Springer,Verlag-Tokyo 2006.
37. Reynolds, C. P., Maurera, B. J., Kolesnick, R. N., Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 2004, 206, 169-180.
38. Maceyka, M., Milstien, S., Spiegel, S., Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. Prostaglandins Other Lipid Mediat. 2005, 77, 15-22.
39. Okada, T., Kajimoto, T., Jahangeer, S., Nakamura, S.-I., Sphingosine kinase/sphingosine 1-phosphate signaling in central nervous system. Cell. Signal. 2008, 21, 7-13.
40. Gurvit, H., Emre, M., Tinaz, S., Bilgic, B. et al., The prevalence of dementia in an urban Turkish population. Am. J. Alzheimers Dis. Other Demen. 2008, 23, 67-76.
41. Satoi, H., Tomimoto, H., Ohtani, R., Kitano, T. et al., Astroglial expression of ceramide in alzheimer's disease brains: A role during neuronal apoptosis. Neuroscience 2005, 130, 657-666.
42. + -ATPase synergistically aggravates ceramide- and β-amyloid-induced apoptosis in cortical neurons. Brain Res. 2002, 955, 253-259.
43. Lee, J.-T., Xu, J., Lee, J.-M., Ku, G. et al., Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 2004, 164, 123-131.
44. Ju, T.-C., Chen, S.-D., Liu, C.-C., Yang, D.-I., Protective effects of S-nitrosoglutathione against amyloid β-peptide neurotoxicity. Free Radic. Biol. Med. 2005, 38, 938-949.
45. He, X., Huang, Y., Li, B., Gong, C.-X. et al., Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol. Aging 2008, Doi:10.1016/j.neurobiolaging.2008.1005.1010.
46. Levade,T., Augé, N., Veldman, R.J., Cuvillier, O. et al., Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 2001, 89, 957-968.
47. Saba, J. D., Hla, T., Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res. 2004, 94, 724-734.
48. Zeidan, Y.H., Hannun, Y.A., Translational aspects of sphingolipid metabolism. Trends Mol. Med. 2007, 13, 327-336.
49. Fracasso, P. M., Brady, M. F., Moore, D. H., Walker, J. L. et al., Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: A gynecologic oncology group study. J. Clin.Oncol. 2001, 19, 2975-2982.
50. Samsel, L, Zaidel, G., Drumgoole, H. M., Jelovac, D. et al., The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate 2004, 58, 382-393.
51. Tiwari, M., Kumar, A., Sinha, R. A., Shrivastava, A. et al., Mechanism of 4-HPR-induced apoptosis in glioma cells: Evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis 2006, 27, 2047-2058.
52. Cascante, M., Boros, L. G., Comin-Anduix, B., Atauri, P. D. et al., Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 2002, 20, 243-249.
53. Schuster, S., Dandekar, T., Fell, D.A., Detection of elementary flux modes in biochemical networks: A promising tool for pathway analysis and metabolic engineering. Trends Biotechnol. 1999, 17, 53-60.
54. Kavun, F. B., Ülgen, K. Ö., Metabolic control analysis and metabolic pathway analysis of sphingolipid metabolism for anticancer drug target identification, 12th European Congress on Biotechnology (ECB 12) 2005. Copenhagen, Denmark.
55. Kavun, F. B., Ülgen, K. Ö., Drug target identification in sphingolipid metabolism by computational systems biology tools: MCA and MPA, 6th International Meeting of the Sphingolipid Club 2007. Bilbao, Spain.